These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 75141)

  • 1. [The role of heparin in thrombin inhibition by antithrombin].
    Bleyl H; Róka L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(6):719-30. PubMed ID: 75141
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of rabbit thrombomodulin on the inhibition of thrombin by the antithrombin-heparin complex: role of the acid domain of thrombomodulin].
    Bourin MC
    C R Acad Sci III; 1987; 304(8):173-6. PubMed ID: 3028582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
    Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Arg46 and Arg47 of antithrombin in heparin binding.
    Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the reliability of the use of heparin immobilized on agarose for the study of the interactions among heparin, thrombin and antithrombin.
    Fish WW; Björk I
    Thromb Haemost; 1982 Aug; 48(1):84-6. PubMed ID: 7135347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A differential effect of low-affinity heparin on the inhibition of thrombin and factor Xa by antithrombin.
    Nordenman B; Nordling K; Björk I
    Thromb Res; 1980 Feb 1-15; 17(3-4):595-600. PubMed ID: 7368180
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of purified plasma kallikrein by antithrombin III and heparin.
    Venneröd AM; Laake K
    Thromb Res; 1975 Jul; 7(1):223-6. PubMed ID: 1154340
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin activity of surface-bound heparin studied under flow conditions.
    Lindhout T; Blezer R; Schoen P; Willems GM; Fouache B; Verhoeven M; Hendriks M; Cahalan L; Cahalan PT
    J Biomed Mater Res; 1995 Oct; 29(10):1255-66. PubMed ID: 8557728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of heparin with lipoproteins - role of the complex in the inactivation of thrombin and plasmin.
    Kecskés E; Büki KG; Bauer PI; Machovich R; Horváth I
    Thromb Haemost; 1983 Apr; 49(2):138-41. PubMed ID: 6223404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct thrombin inhibitors (part 1 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Jan; 17(1):34-8. PubMed ID: 15640538
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombin inhibition by antithrombin in the presence of oversulfated dermatan sulfates.
    Maaroufi RM; Jozefowicz M; Tapon-Bretaudière J; Fischer AM
    Carbohydr Res; 2006 Apr; 341(5):672-6. PubMed ID: 16442510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanisms of action of alpha- and beta-isoforms of antithrombin.
    Swedenborg J
    Blood Coagul Fibrinolysis; 1998 Nov; 9 Suppl 3():S7-10. PubMed ID: 10102493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of collagen on thrombin inactivation by antithrombin-III and heparin.
    Blaskó G; Bédi J; Machovich R; Pálos LA
    Haematologia (Budap); 1977; 11(1-2):163-8. PubMed ID: 615087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E; Vigo A; Pogliani EM
    Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.